Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Regorafenib versus lomustine for relapsed glioblastoma

Dr Giuseppe Lombardi - Istituto Oncologico Veneto, Padova, Italy
Regorafenib versus lomustine for relapsed glioblastoma ( Dr Giuseppe Lombardi - Istituto Oncologico Veneto, Padova, Italy )
9 Sep 2017

Reviewing LORELEI, mindACT and ExteNET trials in breast cancer

Prof Miguel Martin - Hospital General Universitario Gregorio Marañón, Madrid, Spain
Reviewing LORELEI, mindACT and ExteNET trials in breast cancer ( Prof Miguel Martin - Hospital General Universitario Gregorio Marañón, Madrid, Spain )
9 Sep 2017

PACIFIC trial of durvalumab for stage III NSCLC

Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain
PACIFIC trial of durvalumab for stage III NSCLC ( Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain )
9 Sep 2017

Questioning the role of CT-scan in NSCLC post-surgery follow-up

Prof Virginie Westeel - University of Franche-Comté, Besançon, France
Questioning the role of CT-scan in NSCLC post-surgery follow-up ( Prof Virginie Westeel - University of Franche-Comté, Besançon, France )
9 Sep 2017

Osimertinib suitable for first line EGFRm lung cancer

Dr Suresh Ramalingam - Winship Cancer Institute, Atlanta, USA
Osimertinib suitable for first line EGFRm lung cancer ( Dr Suresh Ramalingam - Winship Cancer Institute, Atlanta, USA )
9 Sep 2017

FLAURA study of osimertinib versus TKI for 1st line NSCLC

Dr Suresh Ramalingam - Winship Cancer Institute, Druid Hills, USA
FLAURA study of osimertinib versus TKI for 1st line NSCLC ( Dr Suresh Ramalingam - Winship Cancer Institute, Druid Hills, USA )
9 Sep 2017

Follow-up on the IFCT-0302 trial

Prof Virginie Westeel - University of Franche-Comté, Besançon, France
Follow-up on the IFCT-0302 trial ( Prof Virginie Westeel - University of Franche-Comté, Besançon, France )
9 Sep 2017

PACIFIC trial of durvalumab for lung cancer

Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain
PACIFIC trial of durvalumab for lung cancer ( Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain )
9 Sep 2017

ESMO 2017: CDK4/6 inhibitors from a patient’s perspective

Prof Kimberly Blackwell, Prof Hope Rugo, Prof Peter Schmid, Dr Mark Verrill
ESMO 2017: CDK4/6 inhibitors from a patient’s perspective ( Prof Kimberly Blackwell, Prof Hope Rugo, Prof Peter Schmid, Dr Mark Verrill )
8 Sep 2017

Editor's Choice for August 2017

Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for August 2017 ( Prof Gordon McVie - Founding Editor, ecancer )
23 Aug 2017

Editor's Choice for July 17

Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for July 17 ( Prof Gordon McVie - Founding Editor, ecancer )
28 Jul 2017

iManageCancer: Serious Games for Kids

Stefan Hoffman - Serious Games Solutions, Potsdam, Germany
iManageCancer: Serious Games for Kids ( Stefan Hoffman - Serious Games Solutions, Potsdam, Germany )
28 Jul 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation